MEDEXUS PHARMACEUTICALS INC (MDP.CA) Stock Analyst Ratings
TSX:MDP - Toronto Stock Exchange - CA58410Q2036 - Common Stock - Currency: CAD
ChartMill assigns a Buy % Consensus number of 82% to MDP.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.27. This target is 118.57% above the current price.
MDP.CA was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MDP.CA.
In the previous month the buy percentage consensus was at a similar level.
MDP.CA was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-06 | STIFEL CANADA | Maintains | Buy -> Buy |
| 2022-11-10 | Raymond James Capital | Upgrade | Outperform |
| 2022-10-07 | Canaccord Capital | Upgrade | Hold |
| 2022-09-22 | Canaccord Capital | Downgrade | |
| 2022-09-20 | Raymond James Capital | Downgrade | Market Perform |
| 2022-08-10 | Stifel Nicolaus Research | Downgrade | |
| 2022-07-26 | Raymond James Capital | Initiate | Outperform |
| 2022-03-02 | Raymond James Capital | Upgrade | Outperform |
| 2022-02-22 | Raymond James Capital | Initiate | Outperform |
| 2022-02-22 | Raymond James Financial | Initiate | Outperform |
| 2021-11-12 | NationalBankFinancial | Downgrade | Underperform |
| 2021-08-18 | Canaccord Genuity | Downgrade | Hold |
| 2021-03-02 | Canaccord Genuity | Upgrade | Hold -> Buy |
| 2021-02-17 | Canaccord Genuity | Upgrade | Speculative Buy |